Global Finasteride Tablets Market Professional Survey Report 2016
- QYR589421
- 161 Pages
- June 2016
- Pharmaceuticals
Mainly covers the following product types
The segment applications including
Hospital use
Clinic use
Others
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Merck Sharp & Dohme Australia Pty. Ltd.
Merck & Co, lnc
Ranbaxy Laboratories Ltd
Merck Sharp & Dohme Limited
Sun Pharmaceuticals Industries
Dr.REDDYS Laboratories Ltd
Aurobindo Pharma USA,lnc
Generic
Intas Pharmaceuticals Limited
Teva Pharmaceuticals
Actavis
Hetero Labs Limited
CiPLA LTD
Gedeon Richter Plc
Nanjing Sanhome
Yabao Pharmaceuticals
Hangzhou Conba Group
Yangtze River Pharma
Qianjin Pharma
New Asia Pharma
Shandong Renhetang
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Finasteride Tablets
1.1 Definition and Specifications of Finasteride Tablets
1.1.1 Definition of Finasteride Tablets
1.1.2 Specifications of Finasteride Tablets
1.1.2.1 1mg
1.1.2.2 5mg
1.2 Classification of Finasteride Tablets
1.3 Applications of Finasteride Tablets
1.3.1 Hospital use
1.3.2 Clinic use
1.3.3 Others
1.4 Industry Chain Structure of Finasteride Tablets
1.5 Industry Overview and Major Regions Status of Finasteride Tablets
1.5.1 Industry Overview of Finasteride Tablets
1.5.2 Global Major Regions Status of Finasteride Tablets
1.6 Industry Policy Analysis of Finasteride Tablets
1.7 Industry News Analysis of Finasteride Tablets
2 Manufacturing Cost Structure Analysis of Finasteride Tablets
2.1 Raw Material Suppliers and Price Analysis of Finasteride Tablets
2.2 Equipment Suppliers and Price Analysis of Finasteride Tablets
2.3 Labor Cost Analysis of Finasteride Tablets
2.4 Other Costs Analysis of Finasteride Tablets
2.5 Manufacturing Cost Structure Analysis of Finasteride Tablets
2.6 Manufacturing Process Analysis of Finasteride Tablets
3 Technical Data and Manufacturing Plants Analysis of Finasteride Tablets
3.1 Capacity and Commercial Production Date of Global Finasteride Tablets Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Finasteride Tablets Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Finasteride Tablets Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Finasteride Tablets Major Manufacturers in 2015
4 Global Finasteride Tablets Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Finasteride Tablets Capacity and Growth Rate Analysis
4.2.2 2015 Finasteride Tablets Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Finasteride Tablets Sales and Growth Rate Analysis
4.3.2 2015 Finasteride Tablets Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Finasteride Tablets Sales Price
4.4.2 2015 Finasteride Tablets Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Finasteride Tablets Gross Margin
4.5.2 2015 Finasteride Tablets Gross Margin Analysis (Company Segment)
5 Finasteride Tablets Regional Market Analysis
5.1 North America Finasteride Tablets Market Analysis
5.1.1 North America Finasteride Tablets Market Overview
5.1.2 North America 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Finasteride Tablets Sales Price Analysis
5.1.4 North America 2015 Finasteride Tablets Market Share Analysis
5.2 Europe Finasteride Tablets Market Analysis
5.2.1 Europe Finasteride Tablets Market Overview
5.2.2 Europe 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Finasteride Tablets Sales Price Analysis
5.2.4 Europe 2015 Finasteride Tablets Market Share Analysis
5.3 Japan Finasteride Tablets Market Analysis
5.3.1 Japan Finasteride Tablets Market Overview
5.3.2 Japan 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Finasteride Tablets Sales Price Analysis
5.3.4 Japan 2015 Finasteride Tablets Market Share Analysis
5.4 China Finasteride Tablets Market Analysis
5.4.1 China Finasteride Tablets Market Overview
5.4.2 China 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Finasteride Tablets Sales Price Analysis
5.4.4 China 2015 Finasteride Tablets Market Share Analysis
5.5 Southeast Asia Finasteride Tablets Market Analysis
5.5.1 Southeast Asia Finasteride Tablets Market Overview
5.5.2 Southeast Asia 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Finasteride Tablets Sales Price Analysis
5.5.4 Southeast Asia 2015 Finasteride Tablets Market Share Analysis
5.6 India Finasteride Tablets Market Analysis
5.6.1 India Finasteride Tablets Market Overview
5.6.2 India 2011-2016E Finasteride Tablets Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Finasteride Tablets Sales Price Analysis
5.6.4 India 2015 Finasteride Tablets Market Share Analysis
6 Global 2011-2016E Finasteride Tablets Segment Market Analysis (by Type)
6.1 Global 2011-2016E Finasteride Tablets Sales by Type
6.2 Different Types Finasteride Tablets Product Interview Price Analysis
6.3 Different Types Finasteride Tablets Product Driving Factors Analysis
7 Global 2011-2016E Finasteride Tablets Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Finasteride Tablets Growth Driving Factor Analysis
7.3.2 Clinic use Finasteride Tablets Growth Driving Factor Analysis
7.3.3 Others Finasteride Tablets Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Finasteride Tablets
8.1 Merck Sharp & Dohme Australia Pty. Ltd.
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Merck Sharp & Dohme Australia Pty. Ltd. 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck Sharp & Dohme Australia Pty. Ltd. 2015 Finasteride Tablets Business Region Distribution Analysis
8.2 Merck & Co, lnc
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Merck & Co, lnc 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Merck & Co, lnc 2015 Finasteride Tablets Business Region Distribution Analysis
8.3 Ranbaxy Laboratories Ltd
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Ranbaxy Laboratories Ltd 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Ranbaxy Laboratories Ltd 2015 Finasteride Tablets Business Region Distribution Analysis
8.4 Merck Sharp & Dohme Limited
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Merck Sharp & Dohme Limited 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Merck Sharp & Dohme Limited 2015 Finasteride Tablets Business Region Distribution Analysis
8.5 Sun Pharmaceuticals Industries
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Sun Pharmaceuticals Industries 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sun Pharmaceuticals Industries 2015 Finasteride Tablets Business Region Distribution Analysis
8.6 Dr.REDDYS Laboratories Ltd
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Dr.REDDYS Laboratories Ltd 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Dr.REDDYS Laboratories Ltd 2015 Finasteride Tablets Business Region Distribution Analysis
8.7 Aurobindo Pharma USA,lnc
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Aurobindo Pharma USA,lnc 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Aurobindo Pharma USA,lnc 2015 Finasteride Tablets Business Region Distribution Analysis
8.8 Generic
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Generic 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Generic 2015 Finasteride Tablets Business Region Distribution Analysis
8.9 Intas Pharmaceuticals Limited
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Intas Pharmaceuticals Limited 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Intas Pharmaceuticals Limited 2015 Finasteride Tablets Business Region Distribution Analysis
8.10 Teva Pharmaceuticals
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Teva Pharmaceuticals 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Teva Pharmaceuticals 2015 Finasteride Tablets Business Region Distribution Analysis
8.11 Actavis
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Actavis 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Actavis 2015 Finasteride Tablets Business Region Distribution Analysis
8.12 Hetero Labs Limited
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Hetero Labs Limited 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Hetero Labs Limited 2015 Finasteride Tablets Business Region Distribution Analysis
8.13 CiPLA LTD
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 CiPLA LTD 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 CiPLA LTD 2015 Finasteride Tablets Business Region Distribution Analysis
8.14 Gedeon Richter Plc
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Gedeon Richter Plc 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Gedeon Richter Plc 2015 Finasteride Tablets Business Region Distribution Analysis
8.15 Nanjing Sanhome
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Nanjing Sanhome 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Nanjing Sanhome 2015 Finasteride Tablets Business Region Distribution Analysis
8.16 Yabao Pharmaceuticals
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Yabao Pharmaceuticals 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Yabao Pharmaceuticals 2015 Finasteride Tablets Business Region Distribution Analysis
8.17 Hangzhou Conba Group
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Hangzhou Conba Group 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Hangzhou Conba Group 2015 Finasteride Tablets Business Region Distribution Analysis
8.18 Yangtze River Pharma
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Yangtze River Pharma 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Yangtze River Pharma 2015 Finasteride Tablets Business Region Distribution Analysis
8.19 Qianjin Pharma
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Qianjin Pharma 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Qianjin Pharma 2015 Finasteride Tablets Business Region Distribution Analysis
8.20 New Asia Pharma
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 New Asia Pharma 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 New Asia Pharma 2015 Finasteride Tablets Business Region Distribution Analysis
8.21 Shandong Renhetang
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shandong Renhetang 2015 Finasteride Tablets Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shandong Renhetang 2015 Finasteride Tablets Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Finasteride Tablets Consumption Forecast
9.2.2 Europe 2016-2021 Finasteride Tablets Consumption Forecast
9.2.3 Japan 2016-2021 Finasteride Tablets Consumption Forecast
9.2.4 China 2016-2021 Finasteride Tablets Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Finasteride Tablets Consumption Forecast
9.2.6 India 2016-2021 Finasteride Tablets Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Finasteride Tablets Marketing Model Analysis
10.1 Finasteride Tablets Regional Marketing Model Analysis
10.2 Finasteride Tablets International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Finasteride Tablets by Regions
10.4 Finasteride Tablets Supply Chain Analysis
11 Consumers Analysis of Finasteride Tablets
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Finasteride Tablets
12.1 New Project SWOT Analysis of Finasteride Tablets
12.2 New Project Investment Feasibility Analysis of Finasteride Tablets
13 Conclusion of the Global Finasteride Tablets Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
